Is Valium Addictive? What Long-Term Use Does to the Brain and Body

Many people start Valium for a few weeks of anxiety or muscle spasms, and the prescription keeps getting renewed. Months later, two questions come up: is Valium addictive, and what has all this time on it done? It can be. But being physically dependent on diazepam is not the same as being addicted to it. Below, we explain that difference, why Valium behaves differently from other benzodiazepines, and what FDA labeling and recent research show about memory, the brain, mood, and falls. We also cover why stopping needs a plan, the counterfeit pills found in New Jersey, and what treatment looks like, from therapy to residential rehab in South Jersey for people who need more structure.

Is Valium Addictive?

Yes, Valium can be addictive. The DEA lists diazepam as a Schedule IV controlled substance: it has accepted medical uses along with a potential for misuse and dependence. In 2020, the FDA required a stronger boxed warning on every benzodiazepine, including Valium, covering abuse, misuse, and addiction; physical dependence; withdrawal reactions; and the risks of taking it with opioids.

Four terms are easy to mix up:

• Tolerance: the same dose has less effect over time.
• Physical dependence: the body adapts to diazepam, so lowering or stopping the dose causes withdrawal symptoms. It can happen with regular use exactly as prescribed.
• Misuse: taking Valium in a way it wasn’t prescribed, such as higher doses, more often, or someone else’s pills.
• Benzodiazepine use disorder (addiction): compulsive use, loss of control, and continued use despite harm.

The 2025 Joint Clinical Practice Guideline on Benzodiazepine Tapering says people who are physically dependent are “far more common” than people with a use disorder, and most patients who take benzodiazepines as prescribed will not develop one. In short, diazepam dependence is common; Valium addiction is less common, but real. Nationally, about 4.6 million Americans aged 12 and older (1.6%) misused prescription tranquilizers or sedatives in 2024, and roughly 2.1 million had a tranquilizer or sedative use disorder.

Why Is Valium Different From Other Benzodiazepines?

The FDA approves Valium for anxiety disorders, short-term anxiety symptoms, acute alcohol withdrawal, muscle spasms, and, alongside other medications, seizure disorders. What sets it apart is how long it lasts. According to the FDA prescribing information, diazepam’s elimination half-life is up to 48 hours. The body also turns it into an active metabolite, desmethyldiazepam, with a half-life of up to 100 hours. Age stretches this further: the half-life rises by about 1 hour for each year of age, starting from about 20 hours at age 20, and the label reports “extensive accumulation” with chronic dosing in healthy older adults.

In practice, a dose taken today is still partly active tomorrow. With daily use, each dose adds to what is already in the bloodstream, so levels climb over the first weeks. That can mean next-day drowsiness, slower reactions, or unsteadiness, and in older adults it can persist for as long as the medication continues.

Shorter-acting benzodiazepines such as Xanax (alprazolam) take effect and wear off much faster, so their risks follow a different pattern. Alprazolam is also the most commonly dispensed benzodiazepine in the U.S., at 38% of benzodiazepine prescriptions in 2019 according to the FDA, which makes Xanax addiction statistics in South Jersey a useful point of comparison.

What Does Long-Term Valium Use Do to the Brain and Body?

The long-term effects of Valium build gradually with regular use, and long-term use is common despite limited evidence. The FDA notes that Valium’s effectiveness beyond 4 months hasn’t been evaluated, yet in 2018 about 50% of patients dispensed oral benzodiazepines received them for 2 months or longer. Most of the research below looks at benzodiazepines as a class rather than diazepam alone.

Long-term Valium use: what research shows

Area	What can happen	When it tends to appear
Tolerance	The same dose has less effect; effectiveness beyond 4 months has not been evaluated	With continued regular use
Physical dependence	Withdrawal symptoms when the dose is lowered or stopped	After several days to weeks of steady use, even as prescribed
Memory and thinking	Anterograde amnesia; slower processing; weaker working memory and attention	During use (risk rises with dose); some deficits may outlast stopping
Brain structure	Lower hippocampal and amygdala volume; faster hippocampal loss; no clear rise in dementia risk	Seen in older adults followed for about 11 years
Mood and anxiety	Anxiety returning between doses or when the dose is lowered; worsening of existing depression; paradoxical agitation or aggression	With ongoing use and dose changes; paradoxical reactions are more likely in children and older adults
Coordination, falls, and driving	Drowsiness, unsteadiness, falls, fractures, and motor-vehicle crashes	Any time; risk is higher in adults 65+
Breathing	Profound sedation, respiratory depression, coma, or death when combined with opioids or alcohol	An acute risk at any point, not a long-term effect
Older adults	Slower clearance, drug buildup, cognitive impairment, and delirium	Builds over weeks of daily use
Pregnancy	Newborn sedation (breathing problems, low muscle tone) or withdrawal	With use late in pregnancy

Memory, focus, and thinking

The FDA label lists anterograde amnesia, trouble forming new memories while the drug is active, with the risk rising at higher doses. A 2018 meta-analysis by Crowe and Stranks found that long-term benzodiazepine users scored lower than non-users on working memory, processing speed, divided attention, visuospatial skills, recent memory, and expressive language. People who had stopped still showed deficits in several of these areas. An older 2004 meta-analysis by Barker and colleagues found that function improved in many areas after withdrawal but was still incomplete through the first 6 months, and some deficits may last longer.

Does long-term Valium use cause dementia or brain damage?

Current evidence does not show a clear link to dementia. The Rotterdam Study, published in BMC Medicine in 2024, followed 5,443 cognitively healthy adults (average age about 71) for an average of 11.2 years. Benzodiazepine use was not associated with dementia overall (hazard ratio 1.06, not statistically significant), and the result for diazepam alone was the same. The one exception was the highest cumulative doses of anti-anxiety benzodiazepines, which carried a modestly higher risk (HR 1.33).

On Valium and the brain’s structure, MRI scans showed measurable differences. Among 4,836 participants scanned, current users had smaller hippocampus, amygdala, and thalamus volumes. Over time, they lost hippocampal volume faster, and amygdala volume to a lesser extent. The hippocampus is central to forming new memories, and the amygdala to processing fear and other emotions.

This was an observational study, so it shows an association, not proof that Valium caused the changes. Long-standing anxiety or poor sleep, common reasons for the prescription, may also affect the brain.

Mood, anxiety, and sleep

Valium’s calming effect can weaken as tolerance builds, and anxiety or insomnia can return between doses or when the dose is lowered. The current FDA label warns that benzodiazepines may worsen existing depression. Because Valium is also used for seizures, it carries the anti-seizure drug class warning about suicidal thoughts and behavior. Some people, more often children and older adults, have the opposite reaction to the one intended: agitation, aggression, or hallucinations.

Falls, coordination, and driving

The American Geriatrics Society’s 2023 Beers Criteria advise adults 65 and older to avoid benzodiazepines, including diazepam, with a few exceptions such as seizure disorders and severe generalized anxiety disorder. The reasons: increased sensitivity, slower breakdown of long-acting agents, and higher risks of cognitive impairment, delirium, falls, fractures, and motor-vehicle crashes. At any age, the FDA label cautions against driving, operating machinery, or other activities that require full alertness while taking Valium.

Breathing and dangerous combinations

The most serious danger is acute, not long-term. The FDA boxed warning states that combining benzodiazepines with opioids can cause profound sedation, respiratory depression, coma, and death, and alcohol adds to the same effect. This risk applies on any day Valium is taken.

How Long Does It Take to Become Dependent on Valium?

The FDA’s 2020 safety communication says physical dependence “can occur when benzodiazepines are taken steadily for several days to weeks, even as prescribed.” The 2025 tapering guideline adds that it varies from person to person and estimates when withdrawal becomes clinically significant:

• Use on 3 or fewer days a week, for any length of time: not expected
• Regular use for under a month, or 1–3 months at a low dose: lower risk, but possible
• 1–3 months at a moderate to high dose, or 3+ months at any dose: expected, and greater with higher doses and longer use

The Valium label points the same way: the risks of dependence and withdrawal increase with longer treatment and higher daily doses.

What Are the Signs Valium Use Has Become a Problem?

These are signs worth discussing with a doctor, not a self-diagnosis checklist. Signs of physical dependence, which can happen with prescribed use:

• Needing Valium to feel normal, not just to manage the original symptom
• Anxiety, shakiness, irritability, or poor sleep as a dose wears off
• The usual dose working less well than it did (Valium tolerance)

Signs that may point to Valium addiction or misuse:

• Taking more, or more often, than prescribed
• Running out early or asking for early refills
• Getting prescriptions from more than one prescriber, or pills from friends or online
• Using Valium with alcohol or opioids
• Trying to cut down and not being able to

If any of these sound familiar, they’re worth raising with the prescriber. Other signs you need rehab show up in work, relationships, and health, not just in how the medication is taken.

Why Is Stopping Valium Suddenly Dangerous?

Once the body is dependent, stopping abruptly or cutting the dose quickly can trigger acute withdrawal reactions. The current Valium prescribing information lists symptoms such as anxiety, panic attacks, insomnia, irritability, restlessness, tremor, headache, dizziness, muscle aches, a racing heart, and sensitivity to light and sound. More severe reactions, which can be life-threatening, include seizures, hallucinations, mania, psychosis, and suicidal thoughts. Protracted withdrawal symptoms, such as ongoing anxiety, memory problems, insomnia, and numbness or tingling, may last from weeks to more than 12 months.

The 2025 Joint Clinical Practice Guideline recommends avoiding abrupt discontinuation in anyone likely to be physically dependent. Instead, the prescriber and patient agree on a gradual taper tailored to the individual, slowed or paused if symptoms appear. Valium withdrawal should always be managed with a prescriber, never by skipping doses or stopping alone.

Is the “Valium” Sold on the Street Really Valium?

Not necessarily. In December 2025, the New Jersey State Commission of Investigation reported that New Jersey State Police lab testing found bromazolam, a benzodiazepine never approved for medical use, “increasingly being mixed with fentanyl” and in counterfeit Xanax pills. A November 2025 DEA bulletin counted more than 1,400 seized drug exhibits containing bromazolam and noted that benzodiazepines can complicate overdose reversal. In March 2026, the DEA temporarily placed bromazolam in Schedule I, citing detections in all 50 states.

According to the National Institute on Drug Abuse, 10,870 U.S. overdose deaths involved benzodiazepines in 2023, and nearly 70% of those also involved illicitly manufactured fentanyl. Most documented counterfeits imitate Xanax, but any pill that didn’t come from a pharmacy may not be diazepam at all.

How Is Valium Addiction Treated?

If someone is physically dependent, the first step is a medically supervised plan to reduce the dose safely, managed by the prescriber or, when withdrawal risk is high, a licensed medical detox program. Once the person is medically stable, therapy addresses why the medication became hard to stop:

• Cognitive behavioral therapy to build coping skills that don’t rely on medication
• Treatment for the anxiety, panic, or sleep problem behind the prescription, as part of dual diagnosis care
• Structured residential treatment when outpatient care hasn’t been enough

Maplewood Treatment Solutions in Merchantville, NJ provides residential care for adults with benzodiazepine addiction once they are medically stable; it does not provide detox. If you’re unsure what level of care fits, start with a free, confidential substance use evaluation, by phone or in person. It usually takes 45–60 minutes and requires no insurance.

Valium Can Help Short-Term, but Long-Term Use Needs a Plan

So, is Valium addictive? It can be. Short-term use under a prescriber’s care can be safe, but long-term Valium use brings physical dependence, measurable effects on memory and balance, and withdrawal risks that mean stopping should be planned with a prescriber. If Valium has gone from a short-term fix to something you can’t stop, or you’re helping a family member get into treatment in New Jersey, Maplewood Treatment Solutions offers a free, confidential evaluation to work out what level of care, if any, makes sense. Contact us to talk with our admissions team today.

Frequently Asked Questions

Sources

• American Geriatrics Society Beers Criteria® Update Expert Panel. (2023). American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 71(7), 2052–2081. https://doi.org/10.1111/jgs.18372
• Barker, M. J., Greenwood, K. M., Jackson, M., & Crowe, S. F. (2004). Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: A meta-analysis. Archives of Clinical Neuropsychology, 19(3), 437–454. https://doi.org/10.1016/S0887-6177(03)00096-9
• Brunner, E., Chen, C. A., Klein, T., Maust, D., Mazer-Amirshahi, M., Mecca, M., Najera, D., Ogbonna, C., Rajneesh, K. F., Roll, E., Sanders, A. E., Snodgrass, B., VandenBerg, A., Wright, T., Boyle, M., Devoto, A., Framnes-DeBoer, S., Kleykamp, B., Norrington, J., & Lindsay, D. (2025). Joint clinical practice guideline on benzodiazepine tapering: Considerations when risks outweigh benefits. Journal of General Internal Medicine, 40(12), 2814–2859. https://doi.org/10.1007/s11606-025-09499-2
• Drug Enforcement Administration. (2024). Benzodiazepines [Drug fact sheet]. U.S. Department of Justice. https://www.dea.gov/sites/default/files/2025-01/Benzodiazepines-2024-Drug-Fact-Sheet.pdf
• National Institute on Drug Abuse. (2026, January 26). Drug overdose deaths: Facts and figures. National Institutes of Health. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates
• New Jersey State Commission of Investigation. (2025). Evolving trends and threats in the illicit drug market: Fentanyl, veterinary sedatives, and other emerging synthetic substances. https://www.nj.gov/sci/documents/Complete_Fentanyl_Report_12-16-2025.pdf
• Substance Abuse and Mental Health Services Administration. (2025a). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health (HHS Publication No. PEP25-07-007, NSDUH Series H-60). https://www.samhsa.gov/data/sites/default/files/reports/rpt56287/2024-nsduh-annual-national-report.pdf
• Substance Abuse and Mental Health Services Administration. (2025b). Results from the 2024 National Survey on Drug Use and Health: Detailed tables. https://www.samhsa.gov/data/sites/default/files/reports/rpt56484/NSDUHDetailedTabs2024/NSDUHDetailedTabs2024/2024-nsduh-detailed-tables-sect5pe.htm
• U.S. Food and Drug Administration. (2020, September 23). FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class [Drug Safety Communication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class
• vom Hofe, I., Stricker, B. H., Vernooij, M. W., Ikram, M. K., Ikram, M. A., & Wolters, F. J. (2024). Benzodiazepine use in relation to long-term dementia risk and imaging markers of neurodegeneration: A population-based study. BMC Medicine, 22, Article 266. https://doi.org/10.1186/s12916-024-03437-5
• Waylis Therapeutics LLC. (2026). Valium (diazepam) tablets, for oral use, CIV [Prescribing information]. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/013263s095lbl.pdf